MPHMF — Callitas Health Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Callitas Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.643 | 0.75 | 0.709 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.57 | 0.657 | 0.515 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.65 | 2.4 | 9.06 | 6.7 | 2.3 |
Operating Profit | -4.65 | -2.4 | -8.42 | -5.95 | -1.59 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.98 | -2.07 | -8.58 | -5.47 | -1.7 |
Net Income After Taxes | -3.98 | -2.07 | -8.58 | -5.47 | -1.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.98 | -2.07 | -8.58 | -5.47 | -1.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.98 | -2.07 | -8.58 | -5.47 | -1.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.42 | -0.34 | -0.186 | -0.035 | -0.033 |